Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve

Thrombocytopenia in patients with chronic hepatitis C negatively impacts interferon (IFN)-based treatment. The aim of this study was to evaluate the efficacy and safety of telaprevir (TVR)-based triple therapy including IFN for patients who have undergone partial splenic arterial embolization (PSE)....

Descripción completa

Detalles Bibliográficos
Autores principales: ISHIKAWA, TORU, ABE, SATOSHI, KOJIMA, YUICHI, HORIGOME, RYOKO, SANO, TOMOE, IWANAGA, AKITO, SEKI, KEIICHI, HONMA, TERASU, YOSHIDA, TOSHIAKI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577936/
https://www.ncbi.nlm.nih.gov/pubmed/26622488
http://dx.doi.org/10.3892/etm.2015.2674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577936/
https://www.ncbi.nlm.nih.gov/pubmed/26622488
http://dx.doi.org/10.3892/etm.2015.2674

Ejemplares similares